glutathione glutaredoxin Crystal structure of Human Glutaredoxin
Description
One potential lead is a recent report demonstrating that mESC can proliferate without exogenous glutamine when treated with both a MEK and a GSK3 inhibitor (Carey et al , 2015)
Animal results are useful for generating hypotheses
The type of injury, dose regimen, and general state of health can all affect recovery times
Grant et al
